Long noncoding RNA NEAT1 modulates immune cell functions and is suppressed in early onset myocardial infarction patients

ConclusionThe study indicates distinctive alterations of lncRNA expression in post-MI patient PBMCs. Regarding the monocyte-enrichedNEAT1 suppressed in post-MI patients, the data fromNEAT1−/− mice identifyNEAT1 as a novel lncRNA-type immunoregulator affecting monocyte-macrophage functions and T cell differentiation.NEAT1 is part of a molecular circuit also involving several chemokines and interleukins persistently deregulated post-MI. Individual profiling of this circuit may contribute to identify high-risk patients likely to benefit from immunomodulatory therapies. It also appears reasonable to look for new therapeutic targets within this circuit.
Source: Cardiovascular Research - Category: Cardiology Source Type: research